Author

Sunita Malkani

Observed name: S Malkani

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), University of Delaware

OpenAlex ID: A5113789133

Specific induction of early growth response gene 1 in the lateral nucleus of the amygdala following contextual fear conditioning in rats

2000 · S Malkani, J.B Rosen · Neuroscience · 119

Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs.

1998 · T Hida, J Leyton, et al. · PubMed · 105

N-Methyl-d-aspartate receptor antagonism blocks contextual fear conditioning and differentially regulates early growth response-1 messenger RNA expression in the amygdala: implications for a functional amygdaloid circuit of fear

2001 · S Malkani, J.B Rosen · Neuroscience · 44

Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus

2016 · Jiayi Xu, Songnian Lin, et al. · Bioorganic & Medicinal Chemistry Letters · 26

Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)

2009 · Songnian Lin, Matthew Lombardo, et al. · Bioorganic & Medicinal Chemistry Letters · 21

Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes Mellitus

2016 · Jiayi Xu, Songnian Lin, et al. · Bioorganic & Medicinal Chemistry Letters · 13

Design, synthesis, and biological evaluation of aminopyrazine derivatives as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)

2015 · Songnian Lin, Sunita Malkani, et al. · Bioorganic & Medicinal Chemistry Letters · 12

Works count: 7

Citation count: 340

H-index: 7

I10-index: 7